Drug delivery in a tumour cord model: a computational simulation

The tumour vasculature and microenvironment is complex and heterogeneous, contributing to reduced delivery of cancer drugs to the tumour. We have developed an in silico model of drug transport in a tumour cord to explore the effect of different drug regimes over a 72 h period and how changes in phar...

Full description

Bibliographic Details
Main Authors: Hubbard, Matthew E., Jove, M., Loadman, P.M., Phillips, R.M., Twelves, C.J., Smye, S.W.
Format: Article
Published: Royal Society 2017
Subjects:
Online Access:https://eprints.nottingham.ac.uk/43586/
_version_ 1848796721549672448
author Hubbard, Matthew E.
Jove, M.
Loadman, P.M.
Phillips, R.M.
Twelves, C.J.
Smye, S.W.
author_facet Hubbard, Matthew E.
Jove, M.
Loadman, P.M.
Phillips, R.M.
Twelves, C.J.
Smye, S.W.
author_sort Hubbard, Matthew E.
building Nottingham Research Data Repository
collection Online Access
description The tumour vasculature and microenvironment is complex and heterogeneous, contributing to reduced delivery of cancer drugs to the tumour. We have developed an in silico model of drug transport in a tumour cord to explore the effect of different drug regimes over a 72 h period and how changes in pharmacokinetic parameters affect tumour exposure to the cytotoxic drug doxorubicin. We used the model to describe the radial and axial distribution of drug in the tumour cord as a function of changes in transport rate across the cell membrane, blood vessel and intercellular permeability, flow rate, and the binding and unbinding ratio of drug within the cancer cells. We explored how changes in these parameters may affect cellular exposure to drug. The model demonstrates the extent to which distance from the supplying vessel influences drug levels and the effect of dosing schedule in relation to saturation of drug binding sites. It also shows the likely impact on drug distribution of the aberrant vasculature seen within tumours. The model can be adapted for other drugs and extended to include other parameters. The analysis confirms that computational models can play a role in understanding novel cancer therapies to optimise drug administration and delivery.
first_indexed 2025-11-14T19:52:29Z
format Article
id nottingham-43586
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:52:29Z
publishDate 2017
publisher Royal Society
recordtype eprints
repository_type Digital Repository
spelling nottingham-435862020-05-04T18:46:43Z https://eprints.nottingham.ac.uk/43586/ Drug delivery in a tumour cord model: a computational simulation Hubbard, Matthew E. Jove, M. Loadman, P.M. Phillips, R.M. Twelves, C.J. Smye, S.W. The tumour vasculature and microenvironment is complex and heterogeneous, contributing to reduced delivery of cancer drugs to the tumour. We have developed an in silico model of drug transport in a tumour cord to explore the effect of different drug regimes over a 72 h period and how changes in pharmacokinetic parameters affect tumour exposure to the cytotoxic drug doxorubicin. We used the model to describe the radial and axial distribution of drug in the tumour cord as a function of changes in transport rate across the cell membrane, blood vessel and intercellular permeability, flow rate, and the binding and unbinding ratio of drug within the cancer cells. We explored how changes in these parameters may affect cellular exposure to drug. The model demonstrates the extent to which distance from the supplying vessel influences drug levels and the effect of dosing schedule in relation to saturation of drug binding sites. It also shows the likely impact on drug distribution of the aberrant vasculature seen within tumours. The model can be adapted for other drugs and extended to include other parameters. The analysis confirms that computational models can play a role in understanding novel cancer therapies to optimise drug administration and delivery. Royal Society 2017-05-24 Article PeerReviewed Hubbard, Matthew E., Jove, M., Loadman, P.M., Phillips, R.M., Twelves, C.J. and Smye, S.W. (2017) Drug delivery in a tumour cord model: a computational simulation. Royal Society Open Science, 4 . p. 170014. ISSN 2054-5703 Computational modelling mathematical modelling Drug delivery Drug transport and binding Pharmacokinetic resistance http://rsos.royalsocietypublishing.org/content/4/5/170014 doi:10.1098/rsos.170014 doi:10.1098/rsos.170014
spellingShingle Computational modelling
mathematical modelling
Drug delivery
Drug transport and binding
Pharmacokinetic resistance
Hubbard, Matthew E.
Jove, M.
Loadman, P.M.
Phillips, R.M.
Twelves, C.J.
Smye, S.W.
Drug delivery in a tumour cord model: a computational simulation
title Drug delivery in a tumour cord model: a computational simulation
title_full Drug delivery in a tumour cord model: a computational simulation
title_fullStr Drug delivery in a tumour cord model: a computational simulation
title_full_unstemmed Drug delivery in a tumour cord model: a computational simulation
title_short Drug delivery in a tumour cord model: a computational simulation
title_sort drug delivery in a tumour cord model: a computational simulation
topic Computational modelling
mathematical modelling
Drug delivery
Drug transport and binding
Pharmacokinetic resistance
url https://eprints.nottingham.ac.uk/43586/
https://eprints.nottingham.ac.uk/43586/
https://eprints.nottingham.ac.uk/43586/